Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Clarence Leong"


20 mentions found


This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/world/china/in-china-a-completely-different-approach-to-lowering-healthcare-costs-f5a8ebba
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/business/autos/electric-cars-power-chinas-economic-hopes-as-internet-titans-take-a-back-seat-26c62d3b
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/business/autos/electric-cars-power-chinas-economic-hopes-as-internet-titans-take-a-back-seat-26c62d3b
Persons: Dow Jones
Clarence Leong — Reporter at The Wall Street Journal
  + stars: | 2023-08-17 | by ( Clarence Leong | ) www.wsj.com   time to read: 1 min
Clarence LeongClarence Leong is a reporter for The Wall Street Journal based in Singapore, covering Chinese business and general news. He was previously with Dow Jones Newswires with a focus on Chinese and Hong Kong equities, writing about a range of sectors from real estate to automobiles.
Persons: Clarence Leong Clarence Leong, Dow Jones Organizations: Wall, Journal Locations: Singapore, Hong Kong
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/chinas-tech-distress-grows-as-u-s-chip-sanctions-bite-3022475c
Persons: Dow Jones
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/volkswagen-seeks-to-reclaim-china-crown-in-deal-with-ev-maker-xpeng-27022d8e
Persons: Dow Jones Organizations: volkswagen
Big Pharma Bets Big on China
  + stars: | 2023-07-23 | by ( Clarence Leong | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/big-pharma-bets-big-on-china-2383e6ec
Persons: Dow Jones
Watch: China Sends First Civilian Astronaut to Space Station China sent its first civilian astronaut into orbit on Tuesday, part of a new crew that’s scheduled to spend five months on its space station, Tiangong. WSJ’s Clarence Leong explains the significance behind the mission. Photo: Kevin Frayer/Getty Images
Persons: Clarence Leong, Kevin Frayer Organizations: China, Space
Watch: China Sends First Civilian Astronaut to Space Station China sent its first civilian astronaut into orbit on Tuesday, part of a new crew that’s scheduled to spend five months on its space station, Tiangong. WSJ’s Clarence Leong explains the significance behind the mission. Photo: Kevin Frayer/Getty Images
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/china-launches-three-astronauts-including-first-civilian-into-orbit-898a29b9
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/china-seeks-to-counter-musks-starlink-with-own-satellite-network-ca94aa52
Chinese e-commerce giant Alibaba Group Holding Ltd. said it plans to split itself into six independently run companies that could seek separate IPOs, effectively dismantling a business empire built over two decades by charismatic entrepreneur Jack Ma just as the tycoon reappeared in China. The reorganization of one of China’s largest private companies, once valued at more than $800 billion but now worth about a quarter of that, comes after Chinese authorities signaled in recent months they were winding down a sweeping regulatory clampdown aimed at reining in the country’s powerful tech sector.
Alibaba plans to split itself into six independently run entities. Chinese tech giant Alibaba Group Holding Ltd. plans to split its business into six independently run entities, the biggest structural overhaul in its history—announced a day after co-founder Jack Ma was seen back in mainland China after almost a year overseas. Alibaba Group will become a holding company overseen by current Chairman and Chief Executive Daniel Zhang , the company said in a statement on Tuesday.
The U.S. moved this month to cut off a Chinese conglomerate’s access to Western technology, but the firm can still secure those goods through a technicality that some former senior officials say is a major loophole in the U.S. export-control regime. U.S. companies are barred from exporting to companies named on the Commerce Department’s so-called Entity List, unless they get approval. But listed companies can still buy U.S. goods through subsidiaries that aren’t on the Entity List, current and former government and industry officials say. Industry officials say some U.S. companies intend to keep selling high-tech goods to Chinese companies in that manner.
China Approves First Homegrown mRNA Covid-19 Vaccine
  + stars: | 2023-03-23 | by ( Clarence Leong | ) www.wsj.com   time to read: 1 min
China has relied primarily on inactivated vaccines to protect its population during the pandemic. SINGAPORE—China approved its first homegrown mRNA vaccine for Covid-19, adding a key tool to combat future outbreaks of the virus that was missing due to Beijing’s reluctance to allow Western-made shots using the gene-based technology. CSPC Pharmaceutical Group Ltd.’s messenger-RNA vaccine, known as SYS6006, was given emergency-use clearance by regulators, the company said in a filing to the Hong Kong stock exchange Wednesday. The vaccine was designed to work against the latest variants of Covid-19, and also proved effective against older strains, it said.
SINGAPORE—The failure of Silicon Valley Bank reverberated through startups and venture-capital firms from China to Singapore and India during a roller coaster few days that shook confidence in Asia over reliance on U.S. tech financing. After frantic efforts trying to secure their money, some startup executives said the incident served as a warning despite U.S. authorities stepping in Sunday to shore up the bank’s customers.
Alibaba’s delayed-payment option will first be rolled out in Germany, Spain and France. SINGAPORE—Chinese internet giant Alibaba Group Holding Ltd. started allowing shoppers in Europe to pay for purchases on its international e-commerce platform only after receiving their merchandise, in an attempt to boost global sales as growth at home slows. On Monday, a fintech company called Splitit Payments Ltd. said it would join with Ant Group Co.’s Alipay to provide a delayed-payment option to customers of AliExpress, an online marketplace operated by Alibaba outside of China.
SINGAPORE—China is struggling with shortages of lifesaving antivirals more than a month after its government made an abrupt U-turn on its zero-Covid policies, leaving hospitals and drugmakers unprepared for the rapid rise in cases. Many people in China are hunting for antiviral treatments such as Pfizer Inc.’s Paxlovid and Merck & Co.’s Lagevrio, also known as molnupiravir, which have been shown to suppress the ability of the virus to reproduce when taken soon after a patient gets infected.
Liza Lin — Reporter at The Wall Street Journal
  + stars: | 2023-01-09 | by ( Liza Lin | Dan Strumpf | Karen Hao | ) www.wsj.com   time to read: +1 min
Liza LinLiza Lin covers Asia technology news for The Wall Street Journal from Singapore, focusing mostly on China, the internet, supply chains and surveillance. In 2021, Liza was part of a team at the Journal that was named a finalist for the Pulitzer Prize in International Reporting, for their coverage of Chinese leader Xi Jinping. Liza, alongside other Journal reporters, won the Gerald Loeb Award for International Reporting in 2018 for a series of stories on China's surveillance state. Liza is the co-author with Journal colleague Josh Chin of the book "Surveillance State: Inside China’s Quest to Launch a New Era of Social Control." A Fulbright scholar, she has also worked for Bloomberg News in Singapore and China.
Persons: Liza Lin Liza Lin, Liza, Xi Jinping, Gerald Loeb, Josh Chin Organizations: Wall, New York Press Club, Society of Publishers, Social Control, Bloomberg News Locations: Asia, Singapore, China, Shanghai
SINGAPORE—The consumer-finance arm of China’s Ant Group Co. is planning to raise the equivalent of $1.5 billion in new capital, scaling back its fundraising ambitions after a large state-backed investor backed out of a previous plan. Chongqing Ant Consumer Finance Co., a company that the financial-technology giant set up in mid-2021 to house its personal-lending business, is planning to increase its registered capital to 18.5 billion yuan, equivalent to $2.6 billion, from 8 billion yuan, according to regulatory filings from some of the companies taking part in the capital raise.
Total: 20